166 related articles for article (PubMed ID: 1391505)
1. The role of the kidneys in the excretion of chemically modified hemoglobins.
Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Winslow RM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):737-45. PubMed ID: 1391505
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic studies in the rat on a o-raffinose polymerized human hemoglobin.
Hsia JC; Song DL; Er SS; Wong LT; Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Hess JR; Winslow RM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):587-95. PubMed ID: 1391482
[TBL] [Abstract][Full Text] [Related]
3. Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution.
Keipert PE; Gonzales A; Gomez CL; MacDonald VW; Hess JR; Winslow RM
Transfusion; 1993 Sep; 33(9):701-8. PubMed ID: 8212113
[TBL] [Abstract][Full Text] [Related]
4. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion.
Keipert PE; Gomez CL; Gonzales A; MacDonald VW; Hess JR; Winslow RM
J Lab Clin Med; 1994 May; 123(5):701-11. PubMed ID: 8195676
[TBL] [Abstract][Full Text] [Related]
5. Plasma retention and metabolic fate of hemoglobin modified with an interdimeric covalent cross link.
Keipert PE; Verosky M; Triner L
ASAIO Trans; 1989; 35(2):153-9. PubMed ID: 2730815
[TBL] [Abstract][Full Text] [Related]
6. An improved blood substitute. In vivo evaluation of its renal effects.
Simoni J; Simoni G; Hartsell A; Feola M
ASAIO J; 1997; 43(5):M714-25. PubMed ID: 9360140
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
[TBL] [Abstract][Full Text] [Related]
8. Elimination of pyridoxylated polyhemoglobin after partial exchange transfusion in chimpanzees.
Lenz G; Junger H; Schneider M; Kothe N; Lissner R; Prince AM
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):699-708. PubMed ID: 1810404
[TBL] [Abstract][Full Text] [Related]
9. Clearance of differentially labelled infused hemoglobin and polymerized hemoglobin from dog plasma and accumulation in urine and selected tissues.
Anderson PJ; Ning J; Biro GP
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):781-7. PubMed ID: 1391512
[TBL] [Abstract][Full Text] [Related]
10. Prolonged vascular retention of a hemoglobin solution modified by cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate.
Bleeker WK; van der Plas J; Agterberg J; Rigter G; Bakker JC
J Lab Clin Med; 1986 Nov; 108(5):448-55. PubMed ID: 3772225
[TBL] [Abstract][Full Text] [Related]
11. A natural compound (reuterin) produced by Lactobacillus reuteri for hemoglobin polymerization as a blood substitute.
Chen YC; Chang WH; Chang Y; Huang CM; Sung HW
Biotechnol Bioeng; 2004 Jul; 87(1):34-42. PubMed ID: 15211486
[TBL] [Abstract][Full Text] [Related]
12. Intravascular circulation and distribution of human 51Cr-DBBF stroma-free hemoglobin.
Dittmer J; Ichikura T; Pivacek LE; Giorgio A; Prusty S; Valeri CR
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):751-5. PubMed ID: 1391507
[TBL] [Abstract][Full Text] [Related]
13. Purification and physical characteristics of a hemoglobin solution modified by coupling to 2-nor-2-formylpyridoxal 5'-phosphate (NFPLP).
van der Plas J; de Vries-Van Rossen A; Koorevaar JJ; Buursma A; Zijlstra WG; Bakker JC
Transfusion; 1988; 28(6):525-30. PubMed ID: 2461607
[TBL] [Abstract][Full Text] [Related]
14. Effects of partial and total isovolemic exchange transfusion in fully conscious rats using pyridoxylated polyhemoglobin solution as a colloidal oxygen-delivering blood replacement fluid.
Keipert PE; Chang TM
Vox Sang; 1987; 53(1):7-14. PubMed ID: 3660771
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymerization on clearance and degradation of free hemoglobin.
Bleeker WK; Berbers GA; den Boer PJ; Agterberg J; Rigter G; Bakker JC
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):747-50. PubMed ID: 1391506
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro characteristics of a blood substitute based on pyridoxylated polyhemoglobin.
Keipert PE; Chang TM
Appl Biochem Biotechnol; 1984; 10():133-41. PubMed ID: 6524922
[TBL] [Abstract][Full Text] [Related]
17. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate.
Bleeker WK; van der Plas J; Feitsma RI; Agterberg J; Rigter G; de Vries-van Rossen A; Pauwels EK; Bakker JC
J Lab Clin Med; 1989 Feb; 113(2):151-61. PubMed ID: 2915180
[TBL] [Abstract][Full Text] [Related]
18. HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.
Snyder SR; Welty EV; Walder RY; Williams LA; Walder JA
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7280-4. PubMed ID: 3478694
[TBL] [Abstract][Full Text] [Related]
19. Liposome-encapsulated hemoglobin processing methods.
Zheng S; Zheng Y; Beissinger RL; Fresco R
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):355-64. PubMed ID: 1391451
[TBL] [Abstract][Full Text] [Related]
20. Functional properties of a new crosslinked hemoglobin designed for use as a red cell substitute.
Keipert PE; Adeniran AJ; Kwong S; Benesch RE
Transfusion; 1989; 29(9):768-73. PubMed ID: 2588315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
